ActemraTocilizumab
Actemra is marketed by Cipla. 4 packs on NPPA's price list for July 2026, containing Tocilizumab.
- Packs listed
- 4
- Lowest MRP
- ₹8,915
- Per unit
- ₹8,915 to ₹44,559
- Price-controlled packs
- 0 of 4
- Dosage forms
- 2
Packs and prices
- ₹8,915Actemra 80 mg Injection 1Tocilizumab Injection 80 mg · ₹8,915 per injection
- ₹22,281Actemra 200 mg Injection 1Tocilizumab Injection 200 mg · ₹22,281 per injection
- ₹44,559Actemra 400 mg Injection 1Tocilizumab Injection 400 mg · ₹44,559 per injection
- ₹23,168Actemra 162 mg Prefilled Syringe 0.9 mlTocilizumab Prefilled Syringe 162 mg · ₹23,168 per ml
The company
Cipla has 2,443 packs on the price list, and CDSCO has named it as the manufacturer of 23 failed batches since Jun 2013. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.